WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997036918) PROTEIN MOT12 AND DIAGNOSIS OF INSULIN-DEPENDENT DIABETES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/036918    International Application No.:    PCT/US1997/005284
Publication Date: 09.10.1997 International Filing Date: 25.03.1997
Chapter 2 Demand Filed:    09.10.1997    
IPC:
C07K 14/47 (2006.01), C07K 14/705 (2006.01), C07K 16/18 (2006.01), C12N 9/16 (2006.01)
Applicants: SUGEN, INC. [US/US]; 351 Galveston Drive, Redwood City, CA 94063 (US)
Inventors: PLOWMAN, Gregory, D.; (US)
Agent: WARBURG, Richard, J.; Lyon & Lyon L.L.P., Suite 4700, 633 West Fifth Street, Los Angeles, CA 90071-2066 (US)
Priority Data:
60/014,267 29.03.1996 US
08/816,962 25.03.1997 US
Title (EN) PROTEIN MOT12 AND DIAGNOSIS OF INSULIN-DEPENDENT DIABETES
(FR) PROTEINE MOT12 ET DIAGNOSTIC DE DIABETES DEPENDANT DE L'INSULINE
Abstract: front page image
(EN)The present invention relates to MOT12 polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing. Methods for treatment, diagnosis, and screening are provided for MOT12 related diseases or conditions characterized by an abnormal interaction between a MOT12 polypeptide and a MOT12 binding partner.
(FR)Cette invention concerne des polypeptides MOT12, des acides nucléiques codant ces polypeptides, des cellules, des tissus et des animaux contenant de tels acides nucléiques, des anticorps dirigés contre ces polypeptides, des analyses faisant appel à ces polypeptides et, enfin, des procédés se rapportant aux éléments susmentionnés. Cette invention concerne également des procédés de traitement, de diagnostic et de triage pour des maladies associées à la MOT12, ou pour des états se caractérisant par une interaction anormale entre un polypeptide MOT12 et un partenaire de liaison de MOT12.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TR, TT, UA, UG, UZ, VN.
African Regional Intellectual Property Organization (GH, KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)